Avacta Group plc (GB:AVCT) has released an update.
Avacta Group PLC, a developer of cancer therapeutics and diagnostics, has announced the granting of 3.6 million share options to CEO Christina Coughlin under its Executive Share Option Scheme, with an exercise price of 72p. Additionally, CFO Tony Gardiner exercised 500,000 options at 10p and sold the corresponding shares at an average price of 71.07p, retaining over 2.3 million options. These transactions have resulted in an enlarged issued share capital for the company, now totaling 362,159,730 ordinary shares.
For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.
